Emine Yagci

Dr. Emine Yagci


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2018 in Prostaglandins, Leukotrienes and Essential Fatty Acids
Verified
Journal Article
Closed access
COCansu Ozbayer
Cansu Ozbayer
MKMedine Nur Kebapci
Medine Nur Kebapci
IDIrfan Degirmenci
Irfan Degirmenci
EYEmine Yagci
Emine Yagci
HGHasan Veysi Gunes
Hasan Veysi Gunes
HKHülyam Kurt
Hülyam Kurt

1 January 2025 in Journal of Environmental Pathology, Toxicology and Oncology
Verified
Journal Article
Closed access
PDF file
EYEmine Yagci
Emine Yagci
HKHulyam Kurt
Hulyam Kurt
AOAta Ozen
Ata Ozen
COCansu Ozbayer
Cansu Ozbayer
ECErtugrul Colak
Ertugrul Colak
Prostate cancer and inflammation mechanism are closely related because chronic inflammation causes inflammatory cells to infiltrate into prostatic atrophy areas and proliferative inflammatory atrophy is accepted as the initiator of prostate cancer. The study included 90 patients (28 patients with benign prostatic hyperplasia (BPH), 35 patients with localized prostate cancer (LPCa), and 27 patients with metastatic prostate cancer (MPCa) and 90 healthy controls. Blood samples from 90 patients and 90 healthy people were used to isolate genomic DNA. Serum protein levels were detected using the ELISA technique, and genotyping was done using the PCR-RFLP method. It was found that genotype distributions of CCR3 gene rs4987053 and the COX-2 gene rs689466 variants showed a substantial difference between the groups (Control, BPH, LPCa, MPCa) (respectively P < 0.05, P < 0.001). In addition, a important difference was determined between the non-cancerous and the prostate cancer groups in the NOD1 gene rs5743336 variant genotype distributions (P < 0.05). However, no substantial relationship was determined between the rs16969415, rs1801157, rs2228014, rs2066847, rs4986791 variants, and a risk of prostate cancer. The serum IL-1β, LY96, and TLR4 protein levels differed significantly between the groups (Control, BPH, LPCa, MPCa) (P < 0.001). In addition, IL-1β was associated with rs689466, LY96 with rs2228014, rs5743336 genotypes (P < 0.05). As a conclusion, the CCR3 gene rs4987053, COX-2 gene rs689466, and NOD1 gene rs5743336 variations were determined to be closely associated with prostate cancer risk.

1 January 2024 in OSMANGAZİ JOURNAL OF MEDICINE
Verified
Journal Article
Closed access
EYEmine Yağcı
Emine Yağcı
COCansu Ozbayer
Cansu Ozbayer
GAGuntulu Ak
Guntulu Ak
HKHülyam Kurt
Hülyam Kurt
SMSelma Metintaş
Selma Metintaş
MMMuzaffer Metintas
Muzaffer Metintas
Lung cancer is a malignant lung tumor characterized by uncontrolled cell growth in lung tissue. Genetic and epigenetic abnormalities can be seen in lung cancer. These abnormalities can lead to activation of oncogene and inactivation of tumor suppressor genes. Inflammation is a powerful mediator of cancer development. Pulmonary inflammation may play a role in the initiation or progression of cancer. The main mediator of inflammation is inducible nitric oxide synthase (iNOS), which synthesizes nitric oxide from L-arginine. Monocyte chemoattractant protein-1 (MCP-1) is one of the important chemokines that regulate the migration and infiltration of monocytes/macrophages. It has been determined that MCP-1 plays an important role in lung allergic inflammation, lung leukocyte infiltration and bronchial hyperresponsiveness in the pathogenesis of asthma. Cyclooxygenases (COX) are responsible for prostaglandin production from arachidonic acid. They contribute to inflammation-induced carcinogenesis. COX2 is the enzyme responsible for inflammation induced by inflammatory stimuli, hormones and growth factors. In line with the information given, in this study, serum levels of COX2, iNOS and MCP-1 were determined using the ELISA method in 90 (36 adenocarcinoma, 36 squamous cell, 18 small cell carcinoma) lung cancer patients and 90 healthy control individuals. It was determined that COX2, iNOS and MCP-1 serum concentrations in lung cancer patients were significantly higher than in control individuals (p0.05). It is thought that our findings may contribute to early diagnosis and development of new treatments for lung cancer.

13 April 2023 in Biological Diversity and Conservation
Verified
Journal Article
Open access
PDF file
EYEmine Yağci
Emine Yağci
HÖHikmet Melike Öztürk
Hikmet Melike Öztürk
TÖTufan Öge
Tufan Öge
COCansu Ozbayer
Cansu Ozbayer
HKHülyam Kurt
Hülyam Kurt
Association of PTEN Gene Polymorphisms, Protein Levels and Endometrial Cancer: A Hospital-Based Case-Control Study Emine Yagci1, Hikmet Melike Ozturk1, Tufan Oge2, Cansu Ozbayer3, Hulyam Kurt1 0000-0003-2179-1318, 0000-0002-1951-9713,0000-0002-1120-1874, 0000-0003-2433-9925 1Eskisehir Osmangazi University, Faculty of Medicine, Department of Medical Biology, Eskisehir, Turkey. 2 Eskisehir Osmangazi University, Faculty of Medicine, Department of Gynecology, Eskisehir, Turkey. 3 Kutahya Health Sciences University, Medical Faculty, Department of Medical Biology, Kutahya, Turkey. Corresponding Author: Emine Yagci, Telephone: +90 (222) 2392979/4598, e-mail adress: eminetsci@gmail.com Abstract Endometrial cancer is a type of cancer that develops in the inner lining of the uterus, called the endometrium. After breast, lung, and colon cancer, endometrial cancer is the most prevalent malignancy of the female genital system in industrialized nations like North America and Europe. Phosphatase and Tensin homolog (PTEN), deleted on chromosome 10, is a tumor suppressor gene located on chromosome 10q23.31, which encodes a 403 amino acid protein with both lipid and protein phosphatase activities. One of the most common genetic abnormalities identified in human malignancies are somatic mutations in the PTEN gene. The tumor suppressor activity of the PTEN enzyme is reduced or completely lost as a result of PTEN gene mutations. Considering this information, it is thought that PTEN gene polymorphisms may be associated with the pathogenesis of the disease. The purpose of our study is to determine the relationship between functional PTEN polymorphisms IVS4 (–/+) and -9 C/G and endometrial cancer. DNAs belonging to 63 endometrial cancer patients and 63 control individuals were genotyped by PCR-RFLP method for 2 genetic variants of PTEN IVS4 (–/+) and -9 C/G gene. The expression level of PTEN protein was measured by the Elisa method from serum samples. Our results were evaluated with appropriate statistical methods. As a result of our study, no statistically significant difference was found in the risk of endometrial cancer and genotype frequencies of –9 C/G and IVS4 (-/+) variants (p> 0.05). It was detected that the serum level of PTEN lessened significantly in patients with endometrial cancer in comparison to the control (p

7 September 2026
Verified
Book
Open access
PDF file
SASaid Altıkat
Said Altıkat
İDİrfan Değirmenci
İrfan Değirmenci
YAYeşim Akdeniz
Yeşim Akdeniz
CÖCansu Özbayer
Cansu Özbayer
EYEmine Yağcı
Emine Yağcı
FÖFiliz Özyiğit
Filiz Özyiğit

7 September 2026
Verified
Book Chapter
Closed access
EYEmine Yağcı
Emine Yağcı
CÖCansu Özbayer
Cansu Özbayer